Clinical improvement in a patient with monostotic melorheostosis after treatment with denosumab: a case report

Sarah Byberg, Bo Abrahamsen, Moustapha Kassem, Stuart Ralston, Peter Schwarz

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

95 Downloads (Pure)

Resumé

BACKGROUND: A 20-year-old Danish woman with melorheostosis in her right femoral shaft and disabling pain in the affected area, whose symptoms did not in the long term respond to zoledronic acid, experienced continuous remission of pain after treatment with denosumab. To the best of our knowledge, this is the first case report on denosumab treatment for melorheostosis.

CASE PRESENTATION: Radiologic findings and bone biopsy showed irregular cortical hyperostosis in the right femoral shaft with increased tracer uptake on Tc99-bone scan. The diagnosis of melorheostosis was made based on the radiological findings. There was a good initial response to zoledronic acid administration, but after relapse of pain, the second and third administrations had a poor effect. As a second line of treatment denosumab was administered at 8-week intervals, the frequency was based on our patient's symptoms and on biochemical markers of bone turnover.

CONCLUSION: This is the first report indicating that denosumab has a place in the treatment of melorheostosis when the effect of bisphosphonate treatment is insufficient.

OriginalsprogEngelsk
Artikelnummer278
TidsskriftJournal of Medical Case Reports
Vol/bind12
Antal sider6
ISSN1752-1947
DOI
StatusUdgivet - 27. sep. 2018

Fingeraftryk

Melorheostosis
zoledronic acid

Citer dette

@article{2478444f7cb449c99bf08968a0be8b8b,
title = "Clinical improvement in a patient with monostotic melorheostosis after treatment with denosumab: a case report",
abstract = "BACKGROUND: A 20-year-old Danish woman with melorheostosis in her right femoral shaft and disabling pain in the affected area, whose symptoms did not in the long term respond to zoledronic acid, experienced continuous remission of pain after treatment with denosumab. To the best of our knowledge, this is the first case report on denosumab treatment for melorheostosis.CASE PRESENTATION: Radiologic findings and bone biopsy showed irregular cortical hyperostosis in the right femoral shaft with increased tracer uptake on Tc99-bone scan. The diagnosis of melorheostosis was made based on the radiological findings. There was a good initial response to zoledronic acid administration, but after relapse of pain, the second and third administrations had a poor effect. As a second line of treatment denosumab was administered at 8-week intervals, the frequency was based on our patient's symptoms and on biochemical markers of bone turnover.CONCLUSION: This is the first report indicating that denosumab has a place in the treatment of melorheostosis when the effect of bisphosphonate treatment is insufficient.",
keywords = "Case report, Denosumab, Melorheostosis, Radiography, Young Adult, Recurrence, Denosumab/therapeutic use, Humans, Female, Tomography, X-Ray Computed, Bone Density Conservation Agents/therapeutic use, Melorheostosis/diagnostic imaging",
author = "Sarah Byberg and Bo Abrahamsen and Moustapha Kassem and Stuart Ralston and Peter Schwarz",
year = "2018",
month = "9",
day = "27",
doi = "10.1186/s13256-018-1820-y",
language = "English",
volume = "12",
journal = "Journal of Medical Case Reports",
issn = "1752-1947",
publisher = "BioMed Central",

}

Clinical improvement in a patient with monostotic melorheostosis after treatment with denosumab : a case report. / Byberg, Sarah; Abrahamsen, Bo; Kassem, Moustapha; Ralston, Stuart; Schwarz, Peter.

I: Journal of Medical Case Reports, Bind 12, 278, 27.09.2018.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

TY - JOUR

T1 - Clinical improvement in a patient with monostotic melorheostosis after treatment with denosumab

T2 - a case report

AU - Byberg, Sarah

AU - Abrahamsen, Bo

AU - Kassem, Moustapha

AU - Ralston, Stuart

AU - Schwarz, Peter

PY - 2018/9/27

Y1 - 2018/9/27

N2 - BACKGROUND: A 20-year-old Danish woman with melorheostosis in her right femoral shaft and disabling pain in the affected area, whose symptoms did not in the long term respond to zoledronic acid, experienced continuous remission of pain after treatment with denosumab. To the best of our knowledge, this is the first case report on denosumab treatment for melorheostosis.CASE PRESENTATION: Radiologic findings and bone biopsy showed irregular cortical hyperostosis in the right femoral shaft with increased tracer uptake on Tc99-bone scan. The diagnosis of melorheostosis was made based on the radiological findings. There was a good initial response to zoledronic acid administration, but after relapse of pain, the second and third administrations had a poor effect. As a second line of treatment denosumab was administered at 8-week intervals, the frequency was based on our patient's symptoms and on biochemical markers of bone turnover.CONCLUSION: This is the first report indicating that denosumab has a place in the treatment of melorheostosis when the effect of bisphosphonate treatment is insufficient.

AB - BACKGROUND: A 20-year-old Danish woman with melorheostosis in her right femoral shaft and disabling pain in the affected area, whose symptoms did not in the long term respond to zoledronic acid, experienced continuous remission of pain after treatment with denosumab. To the best of our knowledge, this is the first case report on denosumab treatment for melorheostosis.CASE PRESENTATION: Radiologic findings and bone biopsy showed irregular cortical hyperostosis in the right femoral shaft with increased tracer uptake on Tc99-bone scan. The diagnosis of melorheostosis was made based on the radiological findings. There was a good initial response to zoledronic acid administration, but after relapse of pain, the second and third administrations had a poor effect. As a second line of treatment denosumab was administered at 8-week intervals, the frequency was based on our patient's symptoms and on biochemical markers of bone turnover.CONCLUSION: This is the first report indicating that denosumab has a place in the treatment of melorheostosis when the effect of bisphosphonate treatment is insufficient.

KW - Case report

KW - Denosumab

KW - Melorheostosis

KW - Radiography

KW - Young Adult

KW - Recurrence

KW - Denosumab/therapeutic use

KW - Humans

KW - Female

KW - Tomography, X-Ray Computed

KW - Bone Density Conservation Agents/therapeutic use

KW - Melorheostosis/diagnostic imaging

U2 - 10.1186/s13256-018-1820-y

DO - 10.1186/s13256-018-1820-y

M3 - Journal article

C2 - 30257703

AN - SCOPUS:85054086794

VL - 12

JO - Journal of Medical Case Reports

JF - Journal of Medical Case Reports

SN - 1752-1947

M1 - 278

ER -